Manning & Napier Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.2M Buy
176,281
+768
+0.4% +$88.7K 0.3% 67
2025
Q4
$18.6M Sell
175,513
-11,241
-6% -$1.06M 0.24% 70
2025
Q3
$15.7M Sell
186,754
-71,367
-28% -$5.88M 0.2% 67
2025
Q2
$20.4M Buy
258,121
+189,837
+278% +$15.1M 0.24% 71
2025
Q1
$6.13M Sell
68,284
-6,332
-8% -$591K 0.08% 153
2024
Q4
$7.42M Buy
+74,616
New +$7.69M 0.08% 135
2017
Q3
$29.1M Buy
476,917
+14,719
+3% +$892K 0.25% 75
2017
Q2
$28.3M Buy
462,198
+60,485
+15% +$3.68M 0.24% 72
2017
Q1
$24.4M Buy
401,713
+3,861
+1% +$234K 0.19% 73
2016
Q4
$22.3M Buy
397,852
+45,749
+13% +$2.68M 0.15% 74
2016
Q3
$21M Sell
352,103
-71,707
-17% -$4.19M 0.13% 71
2016
Q2
$23.3M Sell
423,810
-101,823
-19% -$5.42M 0.14% 68
2016
Q1
$26.5M Sell
525,633
-80,960
-13% -$3.97M 0.15% 67
2015
Q4
$30.6M Sell
606,593
-5,868,336
-91% -$296M 0.18% 70
2015
Q3
$305M Sell
6,474,929
-176,977
-3% -$9.4M 1.64% 22
2015
Q2
$361M Buy
6,651,906
+6,234,431
+1,493% +$350M 1.57% 22
2015
Q1
$22.9M Sell
417,475
-923
-0.2% -$52.3K 0.11% 105
2014
Q4
$22.7M Buy
418,398
+22,894
+6% +$1.28M 0.1% 110
2014
Q3
$22.4M Sell
395,504
-2,937
-0.7% -$165K 0.09% 117
2014
Q2
$22M Buy
398,441
+27,979
+8% +$1.53M 0.09% 118
2014
Q1
$20.1M Sell
370,462
-58,361
-14% -$3.02M 0.08% 116
2013
Q4
$20.5M Sell
428,823
-13,482
-3% -$616K 0.09% 109
2013
Q3
$20.1M Buy
442,305
+2,467
+0.6% +$113K 0.09% 102
2013
Q2
$19.5M Buy
+439,838
New +$19.6M 0.1% 99

Other funds holding MRK

Manning & Napier Advisors's MRK Position: Q1 2026 in Review

Manning & Napier Advisors increased its Merck (MRK) stake by 0.44% in Q1 2026, buying an estimated $88.7K and bringing the position to 176,281 shares worth $21.2M. The position accounts for 0.3% of the portfolio, ranked #67.

Manning & Napier Advisors first reported a position in MRK in Q2 2013 and has held it in 24 quarters since. The position peaked at $361M in Q2 2015. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Manning & Napier Advisors held 176,281 shares of Merck worth $21.2M as of Q1 2026.
  • Manning & Napier Advisors bought 768 Merck shares in Q1 2026, an estimated $88.7K.
  • Merck made up 0.3% of Manning & Napier Advisors's portfolio in Q1 2026, its #67 holding.
  • Manning & Napier Advisors first reported a position in Merck in Q2 2013 and has held it in 24 quarters since.
  • Manning & Napier Advisors's Merck position peaked at $361M in Q2 2015.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.